These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1915595)

  • 41. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
    Guo H; Castro PA; Palmiter RD; Baraban SC
    J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS; Buckingham R; Williams G
    Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological characterization of neuropeptide Y-(2-36) binding to neuropeptide Y Y1 and Y2 receptors.
    Schober DA; Gackenheimer SL; Gehlert DR
    Eur J Pharmacol; 1996 Dec; 318(2-3):307-13. PubMed ID: 9016919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction.
    Lundberg JM; Hemsén A; Larsson O; Rudehill A; Saria A; Fredholm BB
    Eur J Pharmacol; 1988 Jan; 145(1):21-9. PubMed ID: 2832184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular characterization of the human neuropeptide Y Y2-receptor.
    Ingenhoven N; Eckard CP; Gehlert DR; Beck-Sickinger AG
    Biochemistry; 1999 May; 38(21):6897-902. PubMed ID: 10346911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Limbic but not non-limbic kindling impairs conditioned fear and promotes plasticity of NPY and its Y2 receptor.
    Botterill JJ; Guskjolen AJ; Marks WN; Caruncho HJ; Kalynchuk LE
    Brain Struct Funct; 2015 Nov; 220(6):3641-55. PubMed ID: 25146309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms.
    Yu XJ; Moskowitz MA
    Br J Pharmacol; 1996 Sep; 119(2):229-32. PubMed ID: 8886402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro.
    Klapstein GJ; Colmers WF
    J Neurophysiol; 1997 Sep; 78(3):1651-61. PubMed ID: 9310450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of [125I]Bolton-Hunter neuropeptide Y binding sites in the forebrain of various mammalian species.
    Martel JC; St-Pierre S; Bédard PJ; Quirion R
    Brain Res; 1987 Sep; 419(1-2):403-7. PubMed ID: 2823968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [125I]Bolton-Hunter neuropeptide-Y-binding sites on folliculo-stellate cells of the pars intermedia of Xenopus laevis: a combined autoradiographic and immunocytochemical study.
    De Rijk EP; Cruijsen PM; Jenks BG; Roubos EW
    Endocrinology; 1991 Feb; 128(2):735-40. PubMed ID: 1989860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
    El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
    Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific neuropeptide Y binding sites in chicken brain.
    Adamo ML; Hazelwood RL
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E839-45. PubMed ID: 1647670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity.
    Wu YF; Li SB
    Acta Pharmacol Sin; 2005 Jan; 26(1):63-8. PubMed ID: 15659116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
    Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
    Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
    El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
    Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Y2 receptors for peptide YY and neuropeptide Y on dispersed chief cells from guinea pig stomach.
    Singh G; Singh L; Raufman JP
    Am J Physiol; 1992 Apr; 262(4 Pt 1):G756-62. PubMed ID: 1314499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells.
    Lobaugh LA; Blackshear PJ
    Am J Physiol; 1990 May; 258(5 Pt 1):C913-22. PubMed ID: 2159234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropeptide Y promotes GTP photo-incorporation into a 55 kDa protein.
    Zhu J; Toews ML; MacDonald RG; Hexum TD
    Eur J Pharmacol; 1994 Aug; 268(3):279-91. PubMed ID: 7805755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of benextramine as an irreversible alpha-adrenergic blocker and as a blocker of potassium-activated calcium channels.
    Plotek Y; Atlas D
    Eur J Biochem; 1983 Jul; 133(3):539-44. PubMed ID: 6134617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.